Table 1.
Summary descriptive data for the YFS cohort in 2001 and 2011. Values are mean (SD) or n (%).
| 2001 | 2011 | |||||
|---|---|---|---|---|---|---|
| All | Male | Female | All | Male | Female | |
| Number of subjects | 2234 | 1004 (44.9) | 1230 (55.1) | 1918 | 860 (44.8) | 1058 (55.2) |
| Age [years] | 31.7 (5.0) | 31.7 (5.0) | 31.7 (5.0) | 41.9 (5.0) | 41.9 (5.1) | 41.9 (5.0) |
| BMI [kg/m²] | 25.1 (4.4) | 25.7 (4.1) | 24.5 (4.6) | 26.5 (5.0) | 27.0 (4.3) | 26.1 (5.5) |
| Daily smokers | 533 (23.9) | 296 (29.5) | 237 (19.3) | 263 (13.7) | 133 (15.5) | 130 (12.3) |
| Cholesterol lowering medicated | 7 (0.3) | 6 (0.6) | 1 (0.1) | 70 (3.6) | 48 (5.6) | 22 (2.1) |
| Diabetes mellitus type 2 | 1 (0.0) | 1 (0.1) | 0 (0.0) | 69 (3.6) | 32 (3.7) | 37 (3.5) |
| Hypertension | 40 (1.8) | 22 (2.2) | 18 (1.5) | 160 (8.3) | 81 (9.4) | 79 (7.5) |
| Total cholesterol [mmol/L] | 5.20 (1.12) | 5.16 (1.06) | 5.24 (1.17) | 5.33 (1.07) | 5.40 (1.12) | 5.27 (1.02) |
| VLDL cholesterol [mmol/L] | 0.81 (0.31) | 0.90 (0.32) | 0.75 (0.29) | 0.76 (0.33) | 0.88 (0.35) | 0.67 (0.27) |
| IDL cholesterol [mmol/L] | 0.83 (0.23) | 0.84 (0.22) | 0.82 (0.23) | 0.86 (0.22) | 0.88 (0.23) | 0.83 (0.20) |
| LDL cholesterol [mmol/L] | 1.94 (0.60) | 2.00 (0.61) | 1.89 (0.60) | 2.05 (0.60) | 2.17 (0.63) | 1.96 (0.57) |
| HDL cholesterol [mmol/L] | 1.78 (0.42) | 1.43 (0.33) | 1.78 (0.42) | 1.65 (0.42) | 1.46 (0.36) | 1.81 (0.40) |
| Triglycerides [mmol/L] | 1.29 (0.69) | 1.45 (0.73) | 1.17 (0.62) | 1.31 (0.87) | 1.57 (0.96) | 1.10 (0.73) |
| apoA-I [g/L] | 1.68 (0.27) | 1.59 (0.21) | 1.76 (0.28) | 1.70 (0.24) | 1.62 (0.21) | 1.77 (0.25) |
| apoB [g/L] | 0.98 (0.24) | 1.03 (0.24) | 0.94 (0.23) | 1.00 (0.25) | 1.08 (0.26) | 0.93 (0.22) |
Abbreviations: BMI, body mass index; VLDL, very-low-density lipoprotein; IDL, intermediate-density lipoprotein; LDL, low-density lipoprotein; HDL, high-density lipoprotein; apoA-I, Apolipoprotein A-I; apoB, Apolipoprotein B.